Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coagulation Protein Disorders”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00581126
What this trial is testing

Study Evaluating BENEFIX in Previously Treated Patients With Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 14
Post-approval studies (Phase 4)Study completedNCT00749476
What this trial is testing

Study Evaluating BeneFIX in Patients With Haemophilia B, Previously Treated With Plasma Derived Factor IX

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 1
Large-scale testing (Phase 3)Active Not RecruitingNCT06738485
What this trial is testing

Recombinant Single-chain Factor VIII (rVIII-SingleChain) in Chinese Participants With Hemophilia A Previously Treated With FVIII Products

Who this might be right for
Congenital Hemophilia A
CSL Behring 60
Post-approval studies (Phase 4)Study completedNCT00092976
What this trial is testing

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 15
Large-scale testing (Phase 3)Study completedNCT01480180
What this trial is testing

Evaluation of Safety and Efficacy, Including Pharmacokinetics, of NNC 0129-0000-1003 When Administered for Treatment and Prophylaxis of Bleeding in Subjects With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 186
Large-scale testing (Phase 3)Study completedNCT01224808
What this trial is testing

Extension Study of Biostate in Subjects With Von Willebrand Disease

Who this might be right for
Von Willebrand Disease
CSL Behring 20
Large-scale testing (Phase 3)UnknownNCT06155955
What this trial is testing

Comparison of Outcomes Between Low Dose Emicizumab and Factor VIII in Clinically Severe Hemophilia A

Who this might be right for
Severe Hemophilia A Without InhibitorJoint Bleed
Chulalongkorn University 15
Not applicableLooking for participantsNCT04119908
What this trial is testing

Videomicroscopy for the Prediction of Bleeding in Constitutional Haemorrhagic Diseases

Who this might be right for
Von Willebrand DiseasesGlanzmann Thrombasthenia
University Hospital, Lille 400
Not applicableStudy completedNCT05138224
What this trial is testing

Prevalence of Autistic Spectrum Disorder (ASD) in Children With Haemophilia

Who this might be right for
HaemophiliaAutism Spectrum DisorderSocial Communication Disorder+1 more
Great Ormond Street Hospital for Children NHS Foundation Trust 82
Large-scale testing (Phase 3)Looking for participantsNCT05568719
What this trial is testing

Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively

Who this might be right for
Hemophilia AHemophilia B
Pfizer 173
Not applicableStudy completedNCT00195221
What this trial is testing

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Who this might be right for
Hemophilia BAllergic Reactions
Wyeth is now a wholly owned subsidiary of Pfizer 166
Not applicableLooking for participantsNCT06816056
What this trial is testing

Manual Therapy in Hemophilic Arthropathy of the Ankle

Who this might be right for
Hemophilia A
Investigación en Hemofilia y Fisioterapia 13
Not applicableUnknownNCT04775888
What this trial is testing

Accessibility of Prophylaxis and On-demand Treatment for Persons With Haemophilia and Other Coagulation Deficiencies

Who this might be right for
Health Services AccessibilityBlood Coagulation Factor Deficiencies
RESCUe - RESeau Cardiologie Urgence / RESUVal - RESeau des Urgences de la vallée du Rhône 500
Large-scale testing (Phase 3)Study completedNCT01913405
What this trial is testing

Phase 3 Efficacy and Safety Study of BAX 855 in Severe Hemophilia A Patients Undergoing Surgical Procedures

Who this might be right for
Hemophilia A
Baxalta now part of Shire 30
Testing effectiveness (Phase 2)Study completedNCT03370172
What this trial is testing

BAX 888 in Male Adults With Severe Hemophilia A

Who this might be right for
Hemophilia A
Baxalta now part of Shire 4
Post-approval studies (Phase 4)Study completedNCT03565237
What this trial is testing

RIXUBIS PMS India (RIXUBIS PMS)

Who this might be right for
Hemophilia B
Baxalta now part of Shire 25
Not applicableNot Yet RecruitingNCT07452575
What this trial is testing

3D Ultrasound in Hemophilic Ankles

Who this might be right for
Hemophilia
The Hospital for Sick Children 11
Large-scale testing (Phase 3)Study completedNCT01286779
What this trial is testing

BAX 326 (rFIX) Continuation Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 117
Post-approval studies (Phase 4)Study completedNCT00950170
What this trial is testing

Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting

Who this might be right for
Hemophilia A
Pfizer 23
Not applicableStudy completedNCT02568202
What this trial is testing

Bridging Hemophilia B Experiences, Results and Opportunities Into Solutions (B-HERO-S)

Who this might be right for
HaemostasisCongenital Bleeding DisorderHaemophilia B
Novo Nordisk A/S 449
Next Page